These contradictory results include reports of different in vitro responses to recombinant WNT5A (rWNT5A) in prostate cancer cells and different prognostic values for WNT5A expression in human prostate cancer tissue [25–30]. This evidence concerns the gene WNT5A and prostate carcinoma.